JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on November 25, 2002; DOI: 10.1124/jpet.102.045575


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.102.045575v1
304/3/1010    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cichewicz, D. L.
Right arrow Articles by McCarthy, E. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cichewicz, D. L.
Right arrow Articles by McCarthy, E. A.

Vol. 304, Issue 3, 1010-1015, March 2003

Antinociceptive Synergy between Delta 9-Tetrahydrocannabinol and Opioids after Oral Administration

Diana L. Cichewicz and Erin A. McCarthy

Department of Pharmacology and Toxicology, Medical College of Virginia, Virginia Commonwealth University, Richmond, Virginia

The analgesic effects of opioids, such as morphine and codeine, in mice are enhanced by oral administration of the cannabinoid Delta 9-tetrahydrocannabinol (Delta 9-THC). However, isobolographic analysis has never been done to confirm a synergy between Delta 9-THC and morphine or codeine via oral routes of administration. To determine the nature of the interaction between these drugs for pain relief and extend previous experimental results, we performed an isobolographic analysis to evaluate for additivity or synergy in the tail-flick test. Fixed-ratio combinations of Delta 9-THC with either morphine or codeine were tested for antinociceptive effects. The experimentally derived ED50 for each combination was compared with the theoretical additive ED50, using an isobolographic analysis. All of the fixed-ratio combinations tested produced greater antinociception (synergy) than predicted from simple additivity. These findings suggest that the use of a low-dose combination of analgesics is a valid and effective approach for the treatment of pain and necessitates further study.


0022-3565/03/3043-1010$07.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2003 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Br J AnaesthHome page
A. Dray
Neuropathic pain: emerging treatments
Br. J. Anaesth., July 1, 2008; 101(1): 48 - 58.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Borner, V. Hollt, and J. Kraus
Cannabinoid Receptor Type 2 Agonists Induce Transcription of the {micro}-Opioid Receptor Gene in Jurkat T Cells
Mol. Pharmacol., April 1, 2006; 69(4): 1486 - 1491.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Grabovsky and R. J. Tallarida
Isobolographic Analysis for Combinations of a Full and Partial Agonist: Curved Isoboles
J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 981 - 986.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.